Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance.

Autor: Sobas MA; Department of Hematology, Blood Neoplasm and Bone Marrow Transplantation, Wroclaw Medical University., Turki AT; Department of Hematology and Oncology, Marienhospital University Hospital, Ruhr-University Bochum, Bochum., Ramiro AV; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca., Hernández-Sánchez A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca, Spain; Hematology Department, University Hospital of Salamanca, Salamanca., Elicegui JM; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca., González T; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca., Melchor RA; Hematology Department, University Hospital of Salamanca, Salamanca., Abáigar M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Cancer Research Center of Salamanca (USAL-CSIC), Salamanca., Tur L; GMV Innovating Solutions, Valencia., Dall'Olio D; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia., Sträng E; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin., Tettero JM; Department of Hematology, Amsterdam University Medical Center location Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Castellani G; Department of Medical and Surgical Sciences - DIMEC, University of Bologna, Bologna., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg., Döhner K; Department of Internal Medicine III, University Hospital Ulm, Ulm., Thiede C; Department of Internal Medicine I, University Hospital Dresden, Dresden., Metzeler KH; Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig., Haferlach T; MLL Munich Leukemia Laboratory, Munich., Damm F; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg., Ayala R; Hematology Department, Hospital Universitario 12 de Octubre, Complutense University CNIO Madrid., Martínez-López J; Hematology Department, Hospital Universitario 12 de Octubre, Complutense University CNIO Madrid., Mills KI; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Sierra J; Hospital Santa Creu Sant Pau, Barcelona., Lehmann S; Uppsala University Hospital, Uppsala., Porta MGD; IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Rozzano, Milan, Italy; and Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Milan., Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University., Reinhardt D; Department of Pediatrics III, University Hospital Essen, University Duisburg-Essen, Essen., Medina RV; GMV Innovating Solutions, Valencia., Schulze-Rath R; Bayer AG, Pharmaceuticals Division, Berlin., Barbus M; AbbVie Deutschland GmbH and Co KG, Wiesbaden., Hernández-Rivas JM; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Hematology Department, University Hospital of Salamanca, Salamanca., Huntly BJP; Department of Haematology and Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge., Ossenkoppele G; Center, Amsterdam UMC,location VUMC, Netherlands., Döhner H; Department of Internal Medicine III, University Hospital Ulm, Ulm., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg. lars.bullinger@charite.de.

Publikováno v: Haematologica [Haematologica] 2024 Nov 07. Date of Electronic Publication: 2024 Nov 07.